{
  "id": 20734475,
  "title": "Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last",
  "url": "https://urgent.news/2026/11/19/novartis-raises-blockbuster-drug-forecasts-to-18-billion-as-it-seeks",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-19T09:57:53.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/11/19/novartis-stock-cmd-2026-ceo.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Novartis forecasts 5% annual sales growth through 2031",
        "url": "https://urgent.news/2026/11/19/novartis-forecasts-5-annual-sales-growth-through-2031",
        "published": "2026-11-19T06:32:33.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}